Dr. Jack West is joined by Dr. David Gandara to discuss blood based testing for molecular interrogation, blood based assays for tumor mutational burden, and how the landscape of lung cancer and the IASLC have evolved. Dr. Gandara is Professor of Medicine and Senior Adviser to the Director of Medical Oncology at University of California Davis in Davis, CA and past president of the IASLC.

Blood Based Testing And The Evolution Of Lung Cancer With Dr. David Gandara

Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 11,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.

Lung Cancer considered is funded in part by Current sponsors: 
•	AbbVie 
•	AstraZeneca
•	Gilead
•	J&J
•	Summit

Science

Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 11,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information. Lung Cancer considered is funded in part by Current sponsors: • AbbVie • AstraZeneca • Gilead • J&J • Summit

Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 11,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.

Lung Cancer considered is funded in part by Current sponsors: 
•	AbbVie 
•	AstraZeneca
•	Gilead
•	J&amp;J
•	Summit

Share Blood Based Testing And The Evolution Of Lung Cancer With Dr. David Gandara

Sign up to save your podcasts

Blood Based Testing And The Evolution Of Lung Cancer With Dr. David Gandara

Blood Based Testing And The Evolution Of Lung Cancer With Dr. David Gandara

More shows like Lung Cancer Considered

This American Life

TED Radio Hour

Planet Money

Marketplace

Pivot

Research To Practice | Oncology Videos

How I Built This with Guy Raz

ASCO Daily News

The Daily

OncLive® On Air

Oncology Today with Dr Neil Love

The Ezra Klein Show

Oncology Brothers: Practice-Changing Cancer Discussions

Good Hang with Amy Poehler

Lung Cancer Rx